REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
13/06/2026
Voltar para busca
Dado oficial do USPTO
ANIMALCELLTHERAPIES
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
49
Atualização mais recente
14/06/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 42
Data de depósito
04/02/2016
Data de registro
13/06/2017
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
15/11/2024
Última transação
14/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
705
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
17/02/2013
Primeiro uso no comércio
17/02/2013
Código do desenho
3
Tipo de titular
03
Localização do titular
Escondido, CA, US
Examinador
KEAN, AMY C
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the words "ANIMALCELLTHERAPIES", with a profile of a dog's head shown in three parts, above the "A" in "ANIMAL".
Titulares e representantes
Titulares
Animal Cell Therapies, Inc.
Animal Cell Therapies, Inc.
Representantes
Jeffrey Sheriff Pillsbury Winthrop Shaw Pittman LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Biological tissuebloodstem cellsumbilical cords and placentas for scientific and medical research use; cells for scientificlaboratory or medical research; laboratory chemicalsan antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; stem cells for research or scientific research purposes
Classe 5
Cells for medical or clinical use; Stem cells for medical or veterinary purposes; Pharmaceutical preparations for use in tissue engineered and cell based veterinary and medical therapies for use in the treatment of osteoarthritisneurologic conditionsinflammatory conditionsimmune- mediated conditionsendocrine diseaseschronic degenerative diseasesgastrointestinal diseases; Pharmaceutical preparations manufactured or modified by genetic engineering in the form of stem cells for veterinary and medical purposes; Pharmaceutical and veterinary preparationsgene therapy products in the form of stem cells for therapeutic medical use; Biochemical preparations namelypreparations for use in gene therapy for the treatment of osteoarthritisneurologic conditionsinflammatory conditionsimmune-mediated conditionsendocrine diseaseschronic degenerative diseasesgastrointestinal diseases; Orthobiologic preparationsbiologic preparations in the nature of stem cells to achieve symptomatic relief and cures from various orthopedic diseases
Classe 42
Medical and scientific research services in the field of animal stem cells for researchdiagnosticclinical use; biopharmaceutical developmentresearch and evaluation services of stem cell-based therapeutics for the treatment of diseaseinjuries and disorders; consulting services in the fields of biotechnologypharmaceutical research and developmentlaboratory testingdiagnosticspharmacogenetics
Publicações
Histórico de despachos e eventos da marca no USPTO.
49 publicações encontradas
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
15/11/2024
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
15/11/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
12/11/2024
PC.D
PETITION TO DIRECTOR DISMISSED
01/11/2024
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
01/11/2024
REIN
REINSTATED
01/11/2024
APET
ASSIGNED TO PETITION STAFF
21/10/2024
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
30/08/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
30/08/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
30/08/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
30/08/2024
TPDR
TEAS PETITION TO DIRECTOR RECEIVED
15/08/2024
NCS8
NOTICE OF CANCELLATION SEC. 8 EMAILED
10/08/2024
C8..
CANCELLED SEC. 8 (6-YR)
10/08/2024
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
12/12/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
17/11/2023
E815
TEAS SECTION 8 & 15 RECEIVED
22/05/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/09/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/09/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/09/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
13/06/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
13/06/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/05/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/05/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
22/04/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
21/04/2017
EX1G
SOU EXTENSION 1 GRANTED
21/04/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
20/04/2017
IUAF
USE AMENDMENT FILED
11/04/2017
EXT1
SOU EXTENSION 1 FILED
11/04/2017
EEXT
SOU TEAS EXTENSION RECEIVED
11/04/2017
EISU
TEAS STATEMENT OF USE RECEIVED
11/04/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/10/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16/08/2016
PUBO
PUBLISHED FOR OPPOSITION
16/08/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
27/07/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/07/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
06/07/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/07/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
06/07/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/07/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/06/2016
GNRT
NON-FINAL ACTION E-MAILED
02/06/2016
CNRT
NON-FINAL ACTION WRITTEN
02/06/2016
DOCK
ASSIGNED TO EXAMINER
19/05/2016
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/02/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/02/2016
NWAP
NEW APPLICATION ENTERED
08/02/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ANIMALCELLTHERAPIES ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.